ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 251 out of 676

$345K Total Retail Price of All Prescriptions

Rank: 314 out of 676

538 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 6,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 415 318 1 2
HYDROCODONE-ACETAMINOPHEN 405 289 S3 2 1
LISINOPRIL 306 256 3 5
SIMVASTATIN 243 188 4 6
AMLODIPINE BESYLATE 223 191 5 3
TRIAMTERENE-HCTZ 184 157 6 43
DICLOFENAC POTASSIUM 180 166 7 199
TRAMADOL HCL 179 151 8 19
METFORMIN HCL 179 129 8 8
ZOLPIDEM TARTRATE 179 121 8 21
ATENOLOL 178 165 11 25
FUROSEMIDE 161 131 12 4
LEVOTHYROXINE SODIUM 160 127 13 7
FLUTICASONE PROPIONATE 139 101 14 49
CIPROFLOXACIN HCL 136 109 15 45
GABAPENTIN 134 80 16 10
CITALOPRAM HBR 132 104 17 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 112 18 16
NABUMETONE 107 99 19 179
POTASSIUM CHLORIDE 98 67 20 9
HYDROCHLOROTHIAZIDE 93 69 21 12
WARFARIN SODIUM 93 71 21 18
GLIPIZIDE ER 89 76 23 103
METHYLPREDNISOLONE 86 74 24 124
RANITIDINE HCL 85 59 25 27
PRAVASTATIN SODIUM 84 60 26 11
METOPROLOL SUCCINATE 83 53 27 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 61 28 74
CARVEDILOL 75 60 29 15
TAMSULOSIN HCL 74 56 30 38
ATORVASTATIN CALCIUM 73 44 31 20
CEFUROXIME 70 47 32 121
SERTRALINE HCL 68 60 33 26
ALLOPURINOL 67 63 34 31
LEVOXYL 66 66 35 186
SYNTHROID 63 60 36 48
DIOVAN HCT 63 54 36 41
MELOXICAM 62 62 38 13
KLOR-CON M20 61 58 39 67
TRAZODONE HCL 59 55 40 36
CRESTOR 59 39 40 29
LOSARTAN-HYDROCHLOROTHIAZIDE 59 48 40 51
CYMBALTA 58 36 43 47
DONEPEZIL HCL 55 55 44 24
GLIMEPIRIDE 55 49 44 30
PROAIR HFA 52 25 46 79
TERAZOSIN HCL 50 47 47 145
PROMETHAZINE HCL 50 31 R 47 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.